1. Home
  2. Publications & Resources
  3. Policy Directives & Guidelines
  4. Tuberculosis - Minimising the risk of Tuberculosis in patients starting Anti TNF Inhibitors
Print this page Reduce font size Increase font size

Tuberculosis - Minimising the risk of Tuberculosis in patients starting Anti TNF Inhibitors

Doc type: Guideline

Doc No.: GL2008_007

Functional Group - Sub Group:
Clinical/ Patient Services - Infectious diseases
Clinical/ Patient Services - Medical Treatment
Population Health - Communicable Diseases

Summary
Guideline to reduce the risk of Tuberculosis disease in patients starting anti-TNF Inhibitors

Date of Publication: 07 April 2008

Replaces: N/A
Author Branch: Communicable Diseases

This document applies to: Area Health Services/Chief Executive Governed Statutory Health Corporation, Board Governed Statutory Health Corporations, Affiliated Health Organisations - Non Declared, Affiliated Health Organisations - Declared, Public Health System Support Division, Community Health Centres, Divisions of General Practice, Government Medical Officers, Public Hospitals

Audience: Administration,k clinical, allied health, nursing

Distributed to: Public Health System, Community Health Centres , Divisions of General Practice, Government Medical Officers, NSW Ambulance Service , NSW Department of Health, Public Health Units, Public Hospitals, Private Hospitals and Day Procedure Centres

Review Date: 07 April 2013

File No: 04/5852

Status: Active

File link: Tuberculosis - Minimising the risk of Tuberculosis in patients starting Anti TNF Inhibitors
File size: 85Kb

Tuberculosis - Minimising the risk of Tuberculosis in patients starting Anti TNF Inhibitors

Print this page Reduce font size Increase font size